Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles W Robinson

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Pediatric Blood & Cancer|April 23, 2013
Impact of tumor location on medulloblastoma subtyping and treatmentGiles W Robinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2020
Genomics Paves the Way for Better Infant Medulloblastoma TherapyGiles W Robinson, Amar Gajjar
Clinical Pharmacology and Therapeutics|August 25, 2017
Development of Molecularly Targeted Therapies to Treat Pediatric MalignanciesClinton F Stewart, Giles W Robinson
Nature Reviews. Clinical Oncology|October 29, 2014
Medulloblastoma-translating discoveries from the bench to the bedsideAmar J Gajjar, Giles W Robinson
Cold Spring Harbor Perspectives in Medicine|November 5, 2013
Role of MYC in MedulloblastomaMartine F Roussel, Giles W Robinson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System TumorsGiles W Robinson, Hendrik Witt, Adam Resnick
CNS Drugs|September 15, 2024
Current Landscape of NTRK Inhibition for Pediatric CNS TumorsDaniel C Moreira, Margit Mikkelsen, Giles W Robinson
Oncology Research and Treatment|April 3, 2017
Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid TumorSanthosh A Upadhyaya, Paul Klimo, Giles W Robinson
BMC Cancer|April 15, 2014
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapyGiles W Robinson, Brent A Orr, Amar Gajjar
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Rare cases of medulloblastoma with hypermutationAditi Bagchi, Ian Beddows, Albert Cornelius, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Pediatric Blood & Cancer|April 23, 2013
Impact of tumor location on medulloblastoma subtyping and treatmentGiles W Robinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2020
Genomics Paves the Way for Better Infant Medulloblastoma TherapyGiles W Robinson, Amar Gajjar
Clinical Pharmacology and Therapeutics|August 25, 2017
Development of Molecularly Targeted Therapies to Treat Pediatric MalignanciesClinton F Stewart, Giles W Robinson
Nature Reviews. Clinical Oncology|October 29, 2014
Medulloblastoma-translating discoveries from the bench to the bedsideAmar J Gajjar, Giles W Robinson
Cold Spring Harbor Perspectives in Medicine|November 5, 2013
Role of MYC in MedulloblastomaMartine F Roussel, Giles W Robinson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System TumorsGiles W Robinson, Hendrik Witt, Adam Resnick
CNS Drugs|September 15, 2024
Current Landscape of NTRK Inhibition for Pediatric CNS TumorsDaniel C Moreira, Margit Mikkelsen, Giles W Robinson
Oncology Research and Treatment|April 3, 2017
Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid TumorSanthosh A Upadhyaya, Paul Klimo, Giles W Robinson
BMC Cancer|April 15, 2014
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapyGiles W Robinson, Brent A Orr, Amar Gajjar
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Rare cases of medulloblastoma with hypermutationAditi Bagchi, Ian Beddows, Albert Cornelius, et al.
Pageof 12